ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 225

Patterns of Joint Involvement in Gout Flares

Ana Beatriz Vargas-Santos1, Yuqing Zhang2, Na Lu1, Nicola Dalbeth3, William J. Taylor4, Jaap Fransen5, Tim Jansen6, H. Ralph Schumacher Jr.7 and Tuhina Neogi1, 1Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, 2Clinical Epidemiology and Training Unit, Boston University School of Medicine, Boston, MA, 3Department of Medicine, University of Auckland, Auckland, New Zealand, 4Department of Medicine, University of Otago, Wellington, New Zealand, 5Rheumatology, Radboud University Medical Center, Nijmegen, Netherlands, 6VieCuri Medical Center, Venlo, Netherlands, 7Medicine, Rheumatology, U Penn & VA Med Ctr, Philadelphia, PA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: gout

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Metabolic and Crystal Arthropathies - Poster I: Clinical Practice

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Gout flares are the most common manifestations of gout. Awareness of possible disease presentations beyond the traditionally recognized podagra is essential for accurate and early diagnosis. Gout flares sparing the first metatarsophalangeal (MTP1) joint may be prone to misdiagnosis as physicians may not consider other patterns of joint involvement in a gout flare. We therefore examined gout flare joint patterns in two large gout cohorts.

Methods: We used data from the Boston Online Gout Study (BOGS), a longitudinal internet-based case-crossover study recruited from the community in the US, and the Study for Updated Gout Classification Criteria (SUGAR), a single time-point international cohort of patients presenting to Rheumatology clinics, to identify patterns of joint involvement and their frequency in gout flares through latent class analysis. In BOGS, we analyzed the joints affected in the first recurrent gout flare reported during the study, while in SUGAR, we analyzed the joints affected at study enrollment. Latent class models with different numbers of classes (patterns) were evaluated, with the optimal number determined by statistical parameters, mean posterior probability of class membership, and clinical judgment.

Results: BOGS included 724 participants, 78% men, mean age 54 years, with mean gout duration of 8 years. SUGAR included 509 subjects with crystal-proven gout, 86% men, mean age 60 years and mean gout duration of 6 years. The optimal model for both studies included four patterns of predominant joint involvement, with mean posterior probability of class membership being ≥79%, indicating a good fit of the group trajectories model. In BOGS, the most common pattern was involvement of lower limb joints (including MTP1), with a prevalence of 49.8%, followed by MTP1 monoarthritis (32.5%), upper limb joint involvement (14.5%), and polyarticular flare (3.1%). Similar patterns were identified in SUGAR, with MTP1 monoarthritis (39.4%) and knee/ankle involvement (37.1%) being the most common, followed by upper limb joint pattern (14.8%) and polyarticular flare (8.6%). (Table) Of note, 43.7% and 64.2% of subjects in BOGS and SUGAR, respectively, had a gout flare in joint(s) other than the MTP1. Upper limb and polyarticular flares appeared to be associated with longer disease duration.

Table. Characteristics of gout flare joint patterns in both cohorts.

Boston Online Gout Study (N=724)

MTP1 monoarthritis

Lower limb1

Upper Limb2

Polyarticular

Prevalence (%)

32.5

49.8

14.5

3.1

N

238

368

97

21

Age, mean ± SD

54.3 ± 12.0

54.7 ± 13.0

55.1 ± 12.1

49.3 ± 10.7

Male, N (%)

187 (78.6)

294 (79.9)

76 (78.4)

11 (52.4)

Gout duration (years), mean ± SD

6.8 ± 9.0

8.1 ± 8.8

10.8 ± 11.4

9.6 ± 9.7

Study for Updated Gout Classification Criteria (N=509)

MTP1 monoarthritis

Knee/ankle

Upper limb2

Polyarticular

Prevalence (%)

39.4

37.1

14.9

8.6

N

177

217

72

43

Age, mean ± SD

62.4 ± 15.3

57.9 ± 14.7

64.3 ± 13.4

60.6 ± 12.8

Male, N (%)

144 (81.4)

195 (89.9)

62 (86.1)

39 (90.7)

Gout duration (years), mean ± SD

6.5 ± 7.8

8.9 ± 8.4

10.2 ± 9.6

12.0 ± 9.6

1: knee, ankle, heel, instep, first metatarsophalangeal joint, other metatarsophalangeal joint; 2: hand, wrist, elbow. MTP: metatarsophalangeal joint; SD: standard deviation.

Conclusion: We identified similar patterns of joint involvement in two large cohorts of gout patients from both the community and Rheumatology practices. While MTP1 monoarthritis was common, other lower extremity joint patterns were also common. These findings are important to increase awareness of different gout flare presentations among health care providers to improve gout flare diagnosis, including a not uncommon pattern of upper limb involvement. Importantly, lack of MTP1 involvement does not rule out the possibility of a gout flare, especially among patients with longer disease duration.


Disclosure: A. B. Vargas-Santos, None; Y. Zhang, None; N. Lu, None; N. Dalbeth, None; W. J. Taylor, None; J. Fransen, None; T. Jansen, None; H. R. Schumacher Jr., None; T. Neogi, None.

To cite this abstract in AMA style:

Vargas-Santos AB, Zhang Y, Lu N, Dalbeth N, Taylor WJ, Fransen J, Jansen T, Schumacher HR Jr., Neogi T. Patterns of Joint Involvement in Gout Flares [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/patterns-of-joint-involvement-in-gout-flares/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patterns-of-joint-involvement-in-gout-flares/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology